Oncology Learning Network
@OncLearnNetwork
Oncology Learning Network® is an online resource for the latest updates in oncology practice. Official digital home for @GreatDebatesCME and @LLMCongress.
You might like
The patient says they feel fine. You notice what they don’t. A cough that changes. Fatigue that runs deeper. At #OLNAPPInstitute, Sri Kota shares practical ways to identify & manage ADC toxicities early so care stays on track. hubs.ly/Q03VlRrR0 #OncologyAPPs #APPeducation
New insights from #SNO25: Updated molecular analyses from the phase 3 ECOG-ACRIN #E3F05 trial demonstrated that the addition of #temozolomide to radiation significantly improved overall survival in grade 2 #glioma. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter
New insights from #SNO25: 3D volumetric RANO provided superior correlation with outcomes vs 2D RANO in patients with IDH1/2-mutant diffuse #glioma treated with #vorasidenib in the #INDIGO trial. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter
Yi-Bin Chen, MD, Massachusetts General Hospital, discusses the treatment course of a patient with chronic GVHD after receipt of an allogeneic stem cell transplant for IDH2-Mutated AML. Learn more: hubs.ly/Q03VsX4n0
Watch Dr. Jia Ruan talk about emerging targeted therapies for peripheral T-cell #Lymphoma in this @OncLearnNetwork video from #LLMCongress: bit.ly/3X89LPO
The FDA granted approval to pembrolizumab or #pembrolizumab and #berahyaluronidase alfa-pmph and enfortumab vedotin-ejfv as neoadjuvant treatment followed by adjuvant treatment after cystectomy for patients with muscle invasive bladder cancer. Learn more: hubs.ly/Q03VrRxQ0
New insights from #AMP25: A 153-gene targeted fusion panel uncovered novel gene fusions, including lncRNA fusion partners, across diverse solid tumors. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter
If your day revolves around keeping patients on track through each phase of treatment, this one’s for you. Join Jeannine Brant at #OLNAPPInstitute to explore how structured pathways can simplify coordination across every stage. hubs.ly/Q03VlNRn0 #APPs #OncologyAPPs
New findings from #AMP2025: The iPLEX HS Lung Panel from @Agena_Bio demonstrated robust analytical accuracy and rapid detection of actionable mutations across 70 recurrent variants in lung cancer. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter
New findings from #AMP25: According to results from a retrospective analysis, MET exon 2 skipping mutations may reflect a self-regulatory mechanism threshold in #NSCLC. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter
For patients with newly diagnosed primary central nervous system #DLBCL, first-line treatment with ibrutinib, rituximab, and high-dose methotrexate demonstrated promising outcomes and manageable safety. Learn more: hubs.ly/Q03Vht-40
Longer-term results from the #INDIGO trial: #Vorasidenib continues to demonstrate clinical benefit and reductions in tumor volume and seizure frequency in grade 2 IDH1/2-mutant diffuse #glioma. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter
Based on results from the phase 3 #DeLLphi304 trial, the @US_FDA has approved #tarlatamab for patients with extensive-stage #SCLC who experience disease progression on or after platinum-based #chemotherapy. Learn more: hmpgloballearningnetwork.com/site/onc/fda-a… #medtwitter #onctwitter
The FDA has granted accelerated approval to #sevabertinib for adults with locally advanced or metastatic non-squamous #NSCLC harboring HER2 (ERBB2) tyrosine kinase domain activating mutations who have received prior systemic therapy. Learn more: hubs.ly/Q03V4W3n0
In a real-world setting, #CAR T-cell therapies including axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel demonstrate superior survival outcomes compared to traditional salvage therapy for patients with #FL. Learn more: hubs.ly/Q03V2BSz0
Based on results from the ANDROMEDA trial, the FDA has approved daratumumab and hyaluronidase in combination with bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed patients with light chain amyloidosis. Learn more: hubs.ly/Q03V2TSr0
On November 19, 2025, the FDA approved #selumetinib for adults with #neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas. Learn more: hubs.ly/Q03V0cpB0
As presented at #ASCP25, CytoRich Red performed better than formalin as a collecting medium for #PCR sequencing among patients with advanced #NSCLC. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter
High-risk CSCC demands collaboration. Join experts from dermatology, oncology, and surgery as they break down real-world strategies for care coordination, IO integration, and precision treatment planning. Free Virtual Summit | Dec 4 Save Your Free Spot → hubs.ly/Q03TStSC0
Keeping pace with rapid shifts in GI, GU, & gynecologic cancer care isn’t easy. Join #OLNAPPInstitute to learn how leading #APPs are tackling real-world challenges & refining treatment decisions with clarity and confidence. Register free: hubs.ly/Q03TVcJR0 #APPeducation
United States Trends
- 1. #AEWFullGear 43.7K posts
- 2. Benavidez 13.2K posts
- 3. Haney 25K posts
- 4. LJ Martin N/A
- 5. Mark Briscoe 3,166 posts
- 6. Georgia Tech 6,255 posts
- 7. Terry Smith 2,423 posts
- 8. #LasVegasGP 130K posts
- 9. Narduzzi 1,480 posts
- 10. #AlianzasAAA 2,029 posts
- 11. Nebraska 24.2K posts
- 12. Rhule 1,987 posts
- 13. Utah 21.3K posts
- 14. Kyle Fletcher 1,716 posts
- 15. #OPLive 2,132 posts
- 16. The Elite 35.2K posts
- 17. Lando 80.2K posts
- 18. Klay 6,132 posts
- 19. Tennessee 22.5K posts
- 20. Heupel 1,498 posts
You might like
-
Mike Pishvaian
@MPishvaian -
Journal of Clinical Oncology
@JCO_ASCO -
Dr. jordan berlin
@jordanberlin5 -
ESMO Open
@ESMO_Open -
Sam Klempner
@KlempnerSam -
OncLive.com
@OncLive -
Kohei shitara
@KoheiShitara -
Great Debates
@GreatDebatesCME -
Eileen M O’Reilly
@EileenMOReilly -
Oncology Brothers
@OncBrothers -
Ghassan Abou-Alfa
@GABOUALFA -
OncologyEducation
@OncEd -
Benjamin Weinberg, MD, FACP
@benweinbergmd -
Lizzy Smyth
@LizzySmyth1 -
Cancer Immunology Research
@CIR_AACR
Something went wrong.
Something went wrong.